Research conducted on PAH associated with congenital heart disease (CHD) indicated that variants in SOX17 might be particularly prevalent in this subgroup, as two out of our seven additional patients presented with CHD. This evidence concerns the gene SOX17 and pulmonary arterial hypertension.